Scilex (SCLX) vs TScan Therapeutics (TCRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Scilex (SCLX) has outperformed TScan Therapeutics (TCRX) over the past year, losing 73.0% versus a loss of 88.5%. Over five years, TCRX leads with a -96.6% price change compared with -98.6% for SCLX. Scilex is the larger company by market cap ($20.8 million vs $15.5 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SCLX | TCRX |
|---|---|---|
| Share price | $2.96 | $0.2282 |
| Market cap | $20.82M | $15.47M |
| 1-day change | -15.19% | -17.59% |
| YTD return | -61.03% | -77.18% |
| 1-year return | -72.96% | -88.47% |
| 5-year return | -98.65% | -96.62% |
| Forward P/E | 4.05 | — |
| EPS (TTM) | $-49.70 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.81 | $2.57 |
| 52-week low | $2.62 | $0.2243 |
| Distance from 52-week high | -82.39% | -91.12% |
| Average volume | 53.62K | 779.81K |
| Shares outstanding | 7.03M | 63.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SCLX has outperformed TCRX by 15.5 percentage points over the past year.
SCLX vs TCRX FAQ
Which is bigger, Scilex or TScan Therapeutics?
Scilex (SCLX) is larger, with a market capitalization of $20.82M compared with $15.47M for TScan Therapeutics (TCRX).
Which stock has performed better over the past year, SCLX or TCRX?
SCLX returned -72.96% over the past 12 months, compared with -88.47% for TCRX (price return, excluding dividends). Past performance does not predict future results.
Are Scilex and TScan Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.